Loading quotes...

Forecast

The analysts' average price target is €213.67 (+2.16%). The median is €214.78 (+2.69%).

Buy	31
Hold	11
Sell	1

News Go to news feed

Danaher raises revenue and profit in third quarter and lifts outlook

Danaher reports a Q3 revenue increase of 8.5% to $6.6 billion and net income of $1.2 billion. Adjusted earnings per share were $2.11, beating the $1.91 expectation; operating cash flow was $1.9 billion and free cash flow rose 19% to $1.63 billion. As a result, Danaher raises its full-year guidance for adjusted EPS to $8.57–$8.62; the stock gains and also lifts Sartorius' preferred share higher. » More on deraktionaer.de
Danaher highlighted by Aristotle Capital for durable healthcare growth

Aristotle Value Equity Fund flagged Danaher as a core holding, citing disciplined capital allocation, the Danaher Business System, strong free cash flow and a high share of recurring consumables revenue. The letter notes Danaher’s transformation into a focused healthcare company through spinoffs and acquisitions such as Pall, Cepheid and Cytiva, which bolstered predictable workflow-based revenues. Danaher shares gained about 10.6% over one month and traded near $215 with a market cap around $155.6 billion; the fund said its overall underperformance in Q2 was due to limited exposure to the AI infrastructure rally. » More on finance.yahoo.com
Danaher shows signs of life sciences recovery after several weak years

Danaher reported improving life‑sciences trends with its Life Sciences unit delivering the strongest performance in years and bioprocessing orders growing mid‑teens, suggesting underlying demand for consumables and equipment is solid. Management said just over $100 million of revenue shifted into next year, indicating delayed rather than lost customer projects, but cut the upper end of its full‑year core revenue growth outlook to 4% due to weakness in biotechnology and respiratory testing. The company’s recovery appears broadening but remains uneven across end markets, leaving investors to weigh near‑term cyclical improvements against lingering pockets of weakness. » More on finance.yahoo.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Danaher has already paid €0.96 in dividends. The last payout was in July.

Financials

In the last quarter, Danaher had revenue of €5.75B and net profit of €1.08B

(EUR)	September 2026	YoY
Revenue	5.75B	11.24%
Gross profit	3.37B	11.89%
Net profit	1.08B	39.74%
EBITDA	1.11B	26.25%

Fundamentals

Metric	Value
Market capitalization	€145.01B
Number of shares	702.99M
52-week high/low	€217.28 - €144.02
Dividend yield	0.60%
Dividends TTM	€1.23
Next dividend	€0.36
Beta	0.80
P/E ratio	37.66
PEG ratio	1.48
P/B ratio	3.03
P/S ratio	6.33

Company profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Name	Danaher
CEO	Julie Sawyer Montgomery
Headquarters	Washington, dc USA
Website	investors.danaher.com
Sector	Health Care
Industry	Health Care Equipment & Supplies
IPO	09/21/2015
Employees	59,000